CureVac Expands Its mRNA Patent Lawsuit Over Pfizer
CureVac NV punched back against Pfizer Inc. and its German partner BioNTech recently by expanding its three claims of patent infringement to nine claims over the mRNA technology used in the companies’ COVID-19 vaccine. CureVac also disclosed that a U.S....
Read More